Loading...
Uploaded by MyelomaUK on Jun 15, 2007
Myeloma UK Chief Executive, Eric Low, speaks about the u-turn by NICE on myeloma drug Velcade -- a move which looks set to approve use of the drug on the NHS after being turned down in 2006
News & Politics
Standard YouTube License
Load more suggestions
Link to this comment:
All Comments (0)